Načítá se...
Selegiline reduces daytime sleepiness in patients with Parkinson's disease
OBJECTIVES: Excessive daytime sleepiness (EDS) affects a large percentage of Parkinson's disease (PD) patients, and it is enhanced by dopamine agonist drugs. Currently, there is no treatment of choice for EDS in PD. Our aim was to check the clinical impression that some patients who were given...
Uloženo v:
| Vydáno v: | Brain Behav |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8119812/ https://ncbi.nlm.nih.gov/pubmed/33759401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1880 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|